Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study

scientific article

Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1378/CHEST.10-0891
P932PMC publication ID3032365
P698PubMed publication ID20688925
P5875ResearchGate publication ID45508324

P50authorOgnjen GajicQ60058244
P2093author name stringRodrigo Cartin-Ceba
Daryl J Kor
Daniel S Talmor
Jason M Erlich
P2860cites workVentilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome NetworkQ27861021
Incidence and outcomes of acute lung injuryQ29615139
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordinationQ29617876
The role of platelets in acute lung injury (ALI)Q30437474
Platelet-neutrophil-interactions: linking hemostasis and inflammationQ30441637
Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregationQ30442280
Postinjury thromboxane receptor blockade ameliorates acute lung injuryQ30471028
Platelet functions beyond hemostasisQ33385887
Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injuryQ33386526
Regulation of neutrophil activation in acute lung injuryQ33698440
Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care settingQ33814687
Neutrophils and acute lung injuryQ33965359
Neutrophil granule contents in the pathogenesis of lung injuryQ33991760
Aspiration pneumonitis and aspiration pneumoniaQ34167919
Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE studyQ34271367
Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working groupQ35093997
Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and managementQ36642058
Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.Q36730287
Acute respiratory distress syndrome in trauma patientsQ36843973
Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational studyQ36916259
Optimal ventilator settings in acute lung injury and acute respiratory distress syndromeQ37001699
Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAsQ37119723
Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort studyQ37147095
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteersQ37225099
Platelets and innate immunityQ37657202
Validation of a combined comorbidity indexQ39605818
Acute lung injury prediction score: derivation and validation in a population-based sampleQ39862179
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit.Q43273337
Rule base system for identification of patients with specific critical care syndromes: The "sniffer" for acute lung injury.Q43995513
Impact of preexisting pulmonary fibrosis detected on chest radiograph and CT on the development of gefitinib-related interstitial lung diseaseQ46322641
Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study GroupQ47228709
Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control studyQ47249875
Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusionQ47784098
Platelet-endothelial cell interaction in pulmonary micro-circulation: the role of PARS.Q50955434
Aspirin effect on early and late changes in acute lung injury in sheep.Q54251275
Diabetic patients have a decreased incidence of acute respiratory distress syndromeQ56287590
Neutrophil elastase as a predicting factor for development of acute lung injuryQ56786523
Influence of aspirin and steroids on acute lung injury after i.v. Injection of a sclerosing agentQ69645911
The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adultsQ70810774
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary reportQ71820554
Clinical risks for development of the acute respiratory distress syndromeQ72501931
Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomyQ80732418
Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injuryQ83274253
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectacute lung injuryQ4677935
P304page(s)289-295
P577publication date2010-08-05
P1433published inChestQ5093377
P1476titlePrehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study
P478volume139

Reverse relations

cites work (P2860)
Q468075860995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide.
Q39262183A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline
Q37119211Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*
Q38193860Advances in ventilator-associated lung injury: prevention is the target
Q37646857Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults
Q52350643Amicus or Adversary Revisited: Platelets in Acute Lung Injury & Acute Respiratory Distress Syndrome.
Q26780333Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
Q39023606Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.
Q35211647Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis
Q35916354Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study
Q35388101Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients
Q47096645Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?
Q36633471Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failure
Q30415074Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness
Q90320152Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers
Q39114910Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?
Q37108944Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*.
Q42218770Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study
Q36018451Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis
Q33745478Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial
Q30244785Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis
Q45097939Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock
Q26822605Emerging therapies for the prevention of acute respiratory distress syndrome
Q38775825Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?
Q39117798Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review.
Q39084380Future therapies for ARDS.
Q88666479High Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-Like Transcript (TLT)-1 Are Associated With Acute Respiratory Distress Syndrome
Q33864069Inflammation and thrombosis in cardiovascular disease.
Q34823885Is there a need for emerging drugs for the acute respiratory distress syndrome?
Q36220113Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury
Q36687227Lung injury prediction score for the emergency department: first step towards prevention in patients at risk
Q38005318Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis.
Q64069094NLRP3 inflammasome activation in platelets in response to sepsis
Q36663432Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study
Q35994453Pathophysiology of pulmonary hypertension in acute lung injury.
Q99404616Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment
Q27022850Pharmacological treatments in ARDS; a state-of-the-art update
Q46500446Platelet Aggregation After Blunt Trauma Is Associated with the Acute Respiratory Distress Syndrome and Altered by Cigarette Smoke Exposure
Q36253991Platelet-derived Wnt antagonist Dickkopf-1 is implicated in ICAM-1/VCAM-1-mediated neutrophilic acute lung inflammation.
Q92556952Platelets and Immune Responses During Thromboinflammation
Q47144868Platelets and Multi-Organ Failure in Sepsis
Q34590168Platelets as immune mediators: Their role in host defense responses and sepsis
Q26739670Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases
Q36237204Platelets in the pathogenesis of acute respiratory distress syndrome
Q28481577Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade
Q33801302Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia
Q34299807Preventing ARDS: progress, promise, and pitfalls
Q27009192Prevention of acute respiratory distress syndrome
Q29353399Prevention or Treatment of Ards With Aspirin: A Review of Preclinical Models and Meta-Analysis of Clinical Studies
Q38629029Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching.
Q33940879Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department
Q36599490Risk factors for the development of acute lung injury in patients with infectious pneumonia
Q33555078Role of diabetes in the development of acute respiratory distress syndrome
Q26822697The acute respiratory distress syndrome
Q48188006The effect of aspirin in transfusion-related acute lung injury in critically ill patients
Q35114925The effect of pre-injury anti-platelet therapy on the development of complications in isolated blunt chest wall trauma: a retrospective study.
Q55018714The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis.
Q48022386Therapeutic effect of Lipoxin A4  in malaria-induced acute lung injury
Q36253821Therapeutic targeting of acute lung injury and acute respiratory distress syndrome

Search more.